Ractigen Therapeutics Unveils Groundbreaking RNA Therapy Data at WMS 2026 #Japan #Hiroshima #Ractigen_Therapeutics #Duchenne_Muscular_Dystrophy #RAG-18

Ractigen Therapeutics Unveils Groundbreaking RNA Therapy Data at WMS 2026 #Japan #Hiroshima #Ractigen_Therapeutics #Duchenne_Muscular_Dystrophy #RAG-18
Long-Term Efficacy and Safety of Brogidirsen for Duchenne Muscular Dystrophy Unveiled at 2026 WMS Congress #United_States #NS_Pharma #Paramus #Duchenne_Muscular_Dystrophy #Brogidirsen
Ractigen Therapeutics to Share Groundbreaking RNA Activation Results at World Muscle Society Congress #Japan #Hiroshima #Ractigen_Therapeutics #Duchenne_Muscular_Dystrophy #RNA_Activation